How have PARD shares performed in 2024?

Poniard Pharmaceuticals' stock was trading at $0.0001 at the beginning of 2024. Since then, PARD stock has increased by 0.0% and is now trading at $0.0001. View the best growth stocks for 2024 here .

How do I buy shares of Poniard Pharmaceuticals?

Shares of PARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:PARD

Poniard Pharmaceuticals (PARD) Stock Price, News & Analysis

→ Never use this word on your phone (FBI could be watching) (From Paradigm Press) (Ad)

Free PARD Stock Alerts

$0.0001

0.00 (0.00%)

(As of 03/26/2024)

Compare

Today's Range: $0.0001
▼
$0.0001
50-Day Range: N/A
52-Week Range: $0.0001
▼
$0.0001

Volume: 100 shs
Average Volume: 3,850 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials

Get Poniard Pharmaceuticals alerts:

Ad Paradigm Press

Dems have chosen Biden replacement?

On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.

See who it is HERE.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington.

PARD Stock Price History

30 days | 90 days | 365 days | Advanced Chart

PARD Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

Receive PARD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Poniard Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 5/06/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:PARD
CUSIP: N/A
CIK: 755806
Web: www.poniard.com
Phone: (206) 281-7001
Fax: 650-583-3789
Employees: 7
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 1.09

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Dr. Robert F. Caspari (Age 76)
Exec. Officer
Dr. Paul G. Abrams
Exec. Officer

Key Competitors

View All Competitors

PARD Stock Analysis - Frequently Asked Questions

How have PARD shares performed in 2024?: Poniard Pharmaceuticals' stock was trading at $0.0001 at the beginning of 2024. Since then, PARD stock has increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here.
How do I buy shares of Poniard Pharmaceuticals?: Shares of PARD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PARD) was last updated on 5/6/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial